Adma Biologics reported $399.56M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Adma Biologics USD 399.56M 68.15M Jun/2025
Alnylam Pharmaceuticals USD 3.64B 375.44M Jun/2025
Dynavax Technologies USD 785.71M 30.26M Jun/2025
Takeda JPY 2.51T 8.07B Jun/2025